Document is current
Any future updates will be listed below
-
Authors
Taguchi, Akira https://orcid.org/0000-0003-2620-1487
Ikegami, Shota
Tokida, Ryosuke
Kamimura, Mikio
Sakai, Noriko
Horiuchi, Hiroshi
Takahashi, Jun
Kato, Hiroyuki
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP18K09758)
Japan Society for the Promotion of Science (JP18K09611)
Japanese Orthopaedic Association (none)
Japanese Society for Musculoskeletal Medicine (none)
Nakatomi Foundation (none)
- License Information
-
More Information
Article History
Received: 3 September 2019
Accepted: 30 October 2019
First Online: 2 January 2020
Compliance with ethical standards
:
: AT has received consulting fees and lecture fees from Asahi-Kasei Pharma, Daiichi-Sankyo, Teijin Pharma, Astellas Pharma, Taisho Pharma, and Chugai Pharmaceutical. MK received lecture fees from Asahi-Kasei Pharma, Teijin Pharma, Ono Pharmaceutical, Pfizer, and Eli Lilly Japan. SI, RT, NS, HH, JT, and HK declare that they have no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
